Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome
Objective. The objective of this study is to explore the relationships of the effects of CYP2C19 and PON1 Q192R polymorphism on the activity of clopidogrel and the risk of high platelet responsiveness (HPR) by thrombelastography in patients with acute coronary syndrome (ACS). Methods. 459 ACS patien...
Saved in:
Main Authors: | Wenxing Peng, Xiujin Shi, Xiaoyu Xu, Yang Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2019/3470145 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
by: Yanti Nasyuhana Sani, et al.
Published: (2013-01-01) -
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China
by: Rong Chang, et al.
Published: (2022-01-01) -
The Role of Thrombelastography in Multiple Trauma
by: Victor Jeger, et al.
Published: (2011-01-01) -
Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel
by: Anil Pareek, et al.
Published: (2025-02-01) -
Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
by: Benjamin T. Maatman, et al.
Published: (2018-01-01)